Tuesday June 18, 2019

Eating An Egg Daily May Keep Diabetes At Bay

In addition, the researchers identified several biochemical compounds in blood that predicted a higher risk of developing Type-2 diabetes, including the amino acid tyrosine

0
//
Reason Why Middle-Aged Men Should Limit Their Protein Intake
An egg a day may keep diabetes away.

Eating an egg daily can have a beneficial effect on the blood metabolite profile that is related to a lower risk of Type-2 diabetes, a new study shows.

The findings showed that the blood samples of men who ate more eggs included certain lipid molecules that positively correlated with the blood profile of men who remained free of Type-2 diabetes.

“The study explored potential compounds that could explain this association using non-targeted metabolomics, a technique that enables a broad profiling of chemicals in a sample,” said lead author Stefania Noerman from the University of Eastern Finland.

Eggs remain one of the most controversial food items.High intake of eggs has traditionally been discouraged, mainly due to their high cholesterol content.

However, eggs are also a rich source of many bioactive compounds that can have beneficial effects on health. This means that the health effects of consuming eggs are difficult to determine based solely on their cholesterol content, the researchers said.

Diabetes
Representational image. Pixabay

For the study, published in Molecular Nutrition and Food Research, 239 serum samples were analysed in four groups: men with higher (mean intake one egg per day) or lower (mean intake two eggs per week) egg intake who developed Type-2 diabetes (cases) or remained healthy (controls) during the mean follow-up of nearly 20 years.

The study suggested some plausible mechanisms which could at least partly explain the inverse association between egg intake and the previously observed lower risk of developing Type-2 diabetes.

Also Read- Protein Found in Spinach May Treat Alcohol Abuse, Mood Disorders

In addition, the researchers identified several biochemical compounds in blood that predicted a higher risk of developing Type-2 diabetes, including the amino acid tyrosine.

“Although it is too early to draw any causal conclusions, we now have some hints about certain egg-related compounds that may have a role in Type-2 diabetes development.

“Further detailed investigations with both cell models and intervention studies in humans that use modern techniques, such as metabolomics, are needed to understand the mechanisms behind physiological effects of egg intake,” Noerman noted. (IANS)

Next Story

Researchers Find Drug to Delay Type-1 Diabetes by Two Years

The effects of the drug were greatest in the first year after it was given, said the study published online in The New England Journal of Medicine

0
Diabetes
Representational image. Pixabay

In a first, researchers have found that a treatment affecting the immune system effectively slowed the progression to clinical Type-1 diabetes in high risk individuals by two years or more.

“The results have important implications for people, particularly youth, who have relatives with the disease, as these individuals may be at high risk and benefit from early screening and treatment,” said Lisa Spain, Project Scientist from US National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The study, involving treatment with an anti-CD3 monoclonal antibody (teplizumab), was conducted by Type 1 Diabetes TrialNet, an international collaboration aimed at discovering ways to delay or prevent Type-1 diabetes.

Participants were randomly assigned to either the treatment group, which received a 14-day course of teplizumab, or the control group, which received a placebo.

All participants received glucose tolerance tests regularly until the study was completed, or until they developed clinical Type-1 diabetes – whichever came first.

During the trial, 72 per cent of the people in the control group developed clinical diabetes, compared to only 43 per cent of the teplizumab group.

diabetes
“Although Type-1 and Type-2 diabetes in parents are well-established risk factors for diabetes, we show that gestational diabetes mellitus may be a risk indicator for diabetes in the mother’s children before age 22,” . Pixabay

The median time for people in the control group to develop clinical diabetes was just over 24 months, while those who developed clinical diabetes in the treatment group had a median time of 48 months before progressing to diagnosis.

“The difference in outcomes was striking. This discovery is the first evidence we’ve seen that clinical Type-1 diabetes can be delayed with early preventive treatment,” Spain added.

Type-1 diabetes develops when the immune system’s T cells mistakenly destroy the body’s own insulin-producing beta cells.

Also Read- Cutting Sodium Intake May Prevent 94 Million Premature Deaths From CVD

Insulin is needed to convert glucose into energy. Teplizumab targets T cells to lessen the destruction of beta cells.

The effects of the drug were greatest in the first year after it was given, said the study published online in The New England Journal of Medicine. (IANS)